13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q1 2024 · Filed May 10, 2024 · Accession 0000904454-24-000285
Total Value
$4.41B
Positions
22
Other Managers
1
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kenvue Inc. | KVUE | 182,329,550 | $3.91B | 88.66% |
| 2 | Fusion Pharmaceuticals Inc. | 36118A100 | 3,670,516 | $78.3M | 1.77% |
| 3 | CVRx, Inc. | CVRX | 4,103,430 | $74.7M | 1.69% |
| 4 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $70.9M | 1.61% |
| 5 | Shockwave Medical, Inc. | 82489T104 | 166,812 | $54.3M | 1.23% |
| 6 | Legend Biotech Corporation | LEGN | 814,586 | $45.7M | 1.04% |
| 7 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $40.3M | 0.91% |
| 8 | Nanobiotix S.A. | NBTX | 5,623,816 | $36.6M | 0.83% |
| 9 | Neumora Therapeutics, Inc. | NMRA | 1,849,445 | $25.4M | 0.58% |
| 10 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $24.8M | 0.56% |
| 11 | Procept BioRobotics Corporation | PRCT | 357,939 | $17.7M | 0.40% |
| 12 | Xencor, Inc. | XNCR | 748,062 | $16.6M | 0.38% |
| 13 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $7.1M | 0.16% |
| 14 | Vor Biopharma, Inc. | VOR | 1,074,658 | $2.5M | 0.06% |
| 15 | Nano-X Imaging Ltd. | NNOX | 158,852 | $1.6M | 0.04% |
| 16 | Aldeyra Therapeutics, Inc. | ALDX | 299,669 | $979,918 | 0.02% |
| 17 | BiomX Inc. | PHGE | 1,923,201 | $865,440 | 0.02% |
| 18 | Adicet Bio, Inc. | ACET | 364,472 | $856,509 | 0.02% |
| 19 | Standard BioTools Inc | LAB | 311,967 | $845,431 | 0.02% |
| 20 | Clearside Biomedical, Inc. | CLSDQ | 169,629 | $259,532 | 0.01% |
| 21 | Tracon Pharmaceuticals, Inc. | 89237H209 | 84,003 | $36,104 | 0.00% |
| 22 | Senseonics Holdings, Inc. | SENS | 54,621 | $29,009 | 0.00% |